Edition:
United Kingdom

NanoCarrier Co Ltd (4571.T)

4571.T on Tokyo Stock Exchange

669JPY
15 Dec 2017
Change (% chg)

¥-8 (-1.18%)
Prev Close
¥677
Open
¥668
Day's High
¥684
Day's Low
¥667
Volume
287,600
Avg. Vol
271,666
52-wk High
¥992
52-wk Low
¥618

Select another date:

Mon, Dec 4 2017

BRIEF-NanoCarrier signs license preferential negotiating rights agreement with AccuRna

* Says it and AccuRna Inc entered into a preferential negotiating rights agreement on exclusive right to license of drug development based on co's gene delivery technology

BRIEF-VBL Therapeutics and Nanocarrier signs agreement for VB-111 in Japan

* VBL Therapeutics and Nanocarrier Co Ltd sign exclusive agreement for VB-111 in Japan

BRIEF-Nanocarrier signs exclusive agreement with VBL Therapeutics for VB-111 in Japan

* Says co signs an exclusive license agreement with VBL Therapeutics, for the development, commercialization, and supply of ofranergene obadenovec ("VB-111") in Japan

BRIEF-NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines

* Says it and NanoCarrier Co., Ltd conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines

BRIEF-NanoCarrier says orphan drug designation of NC-6004 by the U.S. FDA

* Says NC-6004, which is under development in the U.S. for biliary cancer, has been granted to the orphan drug designation from the U.S. FDA (Food and Drug Administration)

BRIEF-NanoCarrier receives orphan drug designation from FDA

* Says its micellar nanoparticles preparation NC-6300 for soft tissue sarcomas has been designated to orphan drug by Food and Drug Administration (FDA) in U.S.

Select another date: